13F-HR filed by Northpond Ventures, LLC
Northpond Ventures, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-01, with 5 holding rows worth $184,349,014.
- Accession
- 0001104659-23-009328
- Filer
- CIK 1911245
- Filed
- 2023-02-01
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 5 entries on the cover page, a total value of $184,349,014 stated on the cover page (in dollars after the unit check, H1), rows summing to $184,349,014 with VALUE read as dollars as filed, 13F file number 028-22233. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DICE THERAPEUTICS INC | 23345J104 | COM | 3,292,871 | $102,737,575 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 4,214,498 | $52,681,225 | dollars as filed | |
| ISOPLEXIS CORP | 465005106 | COM | 8,808,531 | $13,653,223 | dollars as filed | |
| CODEX DNA INC | 192003101 | COM | 9,844,130 | $11,812,956 | dollars as filed | |
| CANDEL THERAPEUTICS INC | 137404109 | COMMON STOCK | 1,935,215 | $3,464,035 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-009328 | this filing | 2023-02-01 | acceptance time not in the bulk data set |